Advanced Search
ZHOU Zhiguo, ZHEN Chanjun, LIANG Junli, ZHANG Ping, LIU Xin, BAI Wenwen, QIAO Xueying, SONG Yuzhi, GAO Xianshu. Comparison of 6th and 7th Editions of AJCC/UICC TNM Staging for Esophageal Cancer Patients Received Radiotherapy[J]. Cancer Research on Prevention and Treatment, 2015, 42(08): 772-776. DOI: 10.3971/j.issn.1000-8578.2015.08.005
Citation: ZHOU Zhiguo, ZHEN Chanjun, LIANG Junli, ZHANG Ping, LIU Xin, BAI Wenwen, QIAO Xueying, SONG Yuzhi, GAO Xianshu. Comparison of 6th and 7th Editions of AJCC/UICC TNM Staging for Esophageal Cancer Patients Received Radiotherapy[J]. Cancer Research on Prevention and Treatment, 2015, 42(08): 772-776. DOI: 10.3971/j.issn.1000-8578.2015.08.005
shu

Comparison of 6th and 7th Editions of AJCC/UICC TNM Staging for Esophageal Cancer Patients Received Radiotherapy

  • 1. No. 5 Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China; 2. Department of Radiation Oncology, Peking University First Hospital, Beijing 100034, China

More Information
  • Received Date: September 04, 2014
  • Revised Date: February 09, 2015
    Graphical Abstract
    • Abstract
  • Objective To evaluate the reasonability of the 6th and 7th editions of American Joint Committee on Cancer/Union for International Cancer Control(AJCC/UICC) tumor node metastasis(TNM) staging foresophageal carcinoma in radiotherapy and their effect on prognosis. Methods We retrospectively analyzed 265 esophageal carcinoma patients received radiotherapy. In accordance with different definition about location segment in the 6th and 7th edition of AJCC/UICC TNM staging for esophageal carcinoma, we analyzed and evaluated the prognosis by univariate and multivariate survival analysis. Results According to the 7th edition of AJCC/UICC TNM staging for esophageal carcinoma, the number of esophagus primary lesions in cervical, upper, middle and inferior thoracic portion were 46, 76, 83 and 60, respectively, according to the 6th edition, the number were 16, 83, 132 and 34, respectively. All patients were divided into two groups according to the two methods, the consistent group (169 cases) and the difference group (96 cases). In consistent group, the 1-, 2-, 3-year survival rates of patients with esophageal carcinoma in cervical, upper, middle and inferior thoracic portion were 70.6%, 64.7%, 64.7%；84.3%, 57.8%, 53.6%；53.4%, 32.7%, 21.0% and 71.4%, 40.2%, 40.2%, respectively(P=0.001). The difference wasn't signi?cant statistically in the difference group. Multivariate analysis showed that age, the 6th edition of TNM staging and radiation dose were independent factors for the survival. Conclusion The difference of two staging methods on the esophageal carcinoma in cervical, middle and inferior thoracic portion is obvious. The 6th edition of AJCC/UICC TNM staging could better predict the survival. The survival of patients with esophageal carcinoma in cervical and upper thoracic portion after radiotherapy is superior to those in the middle and inferior thoracic portion.
    • FullText(HTML)
    • References (14)
  • [1]
    Rice TR, Blackstone EH, Rusch VW. 7th Edition of the AJCC cancer staging manual: esophagus and esophagogastric junction[J]. Ann Surg Oncol, 2010, 17(7): 1721-4.
    [2]
    Chen LQ. Defining AJCC/UICC esophageal cancer TNM stag ing 7t h edition(2009)[J]. Zhongguo Xiong Xin Xue Guan Wai Ke Lin Chuang Za Zhi, 2008, 15(1): 52-5. [陈龙奇. 制订2009第7版食管 癌TNM分期标准[J]. 中国胸心血管外科临床杂志, 2008, 15(1): 52 -5.]
    [3]
    Talsma K, van Hagen P, Grotenhuis BA, et al. Comparison of the 6t h and 7th Editions of the UICC-AJCC TNM Classification for Esophageal Cancer[J]. Ann Surg Oncol, 2012, 19(7): 2142-8.
    [4]
    He J, Wang JJ, Qian JX, et al. Comparison of the predictive value of the 6th and the 7th editions of the UICC-AJCC TNM staging systems in prognosis of esophageal cancer after radical resection: Analysis of 400 patients with esophageal cancer[J]. Zhong Liu, 2013, 33(2): 164-70. [何健, 王杰军, 钱建 新, 等. 第6版和第7版UICC-AJCC TNM分期系统预测食管癌 根治性切除术后生存情况的比较：基于400例食管癌患者的临 床分析[J]. 肿瘤, 2013, 33(2): 164-70. ]
    [5]
    Yang JS, Yang WP, Chen YP, et al. Operative treatment of 306 cases with high esophageal careinoma[J]. Lin Chuang Zhong Liu Xue Za Zhi, 1999, 4(3): 18-9. [杨捷生, 杨卫平, 陈于平, 等. 手术治疗高位食管癌306例[J]. 临床肿瘤学杂志, 1999, 4(3): 18-9.]
    [6]
    Wang WG, Li JD, Qi JX, et al. Experence of surgical treatment for cervical esophageal carcinoma[J]. Zhonghua Wei Chang Wai Ke Za Zhi, 2008, 11(1): 19-23. [王文光, 李进东, 齐金星, 等. 颈段食 管癌的外科治疗[J].中华胃肠外科杂志, 2008, 11(1): 19-23. ]
    [7]
    Zhu SC, Li R, Wang YX, et al. Prognostic factors of locally advanced esophageal carcinoma treated by radiotherapy alone[J]. Zhonghua Fang She Zhong Liu Xue Za Zhi, 2005, 14(4): 253-8. [祝淑钗, 李任, 王玉祥, 等. 500例中晚期食管癌单纯放疗的多 因素分析[J]. 中华放射肿瘤学杂志, 2005, 14(4): 253-8. ]
    [8]
    Wang L, Kong J, Han C, et al. Prognositic analysis of cervical, upper-thoracic, middle-thoracic, and lower-thoracic esophageal cancers in 781 patients mainly receiving three-dimensional radiotherapy[J]. Zhonghua Fang She Zhong Liu Xue Za Zhi, 2013, 22 (1): 18-21. [王澜, 孔洁, 韩春, 等. 781例不同部位食管癌三维 放疗预后分析[J]. 中华放射肿瘤学杂志, 2013, 22(1): 18-21.]
    [9]
    Wang YX, Zhu SC, Su JW, et al. Prognostic analysis of threedimensional conformal radiotherapy(3D-CRT)for cervical and upper-thoracic esopageal cancer[J]. Zhong Liu Fang Zhi Yan Jiu, 20 11, 38(1): 93-7. [王玉祥, 祝淑钗, 苏景伟, 等. 颈及胸上段 食管癌三维适形放射治疗疗效分析[J]. 肿瘤防治研究, 2011, 38 (1): 93-7. ]
    [10]
    Xiao ZF, Yang ZY, Wang LH, et al. Influence of the number of lymph node metastasis on survival and significance of postoperative radiotherapy for esophageal carcinoma[J]. Zhonghua Zhong Liu Za Zhi, 2004, 26(2): 112-5. [肖泽芬, 杨宗 贻, 王绿化, 等. 食管癌术后淋巴结转移对生存率的影响和放射 治疗的意义[J]. 中华肿瘤杂志, 2004, 26(2): 112-5. ]
    [11]
    Li CL, Wang YD. Lymphnode metastasis of thoracic esophageal cancer after lymphnode dissection:providing guidance for postoperative radiotherapy target[J]. Zhong Liu Fang Zhi Yan Jiu, 20 11, 38(11): 1332-4. [李成林, 王雅棣. 食管癌术后淋巴结转移 规律及放疗靶区探讨[J]. 肿瘤防治研究, 2011, 38(11): 1332-4. ]
    [12]
    Zhen CJ, Zhou ZG, Qiao XY, et al. Retrospective study on staging of esophageal cancer with supra-clavicular lymph node metastasis:an anaylsis of 152 cases[J]. Zhongguo Zhong Liu Lin Chuang, 2011, 38(23): 1458-63. [甄婵军, 周志国, 乔学英, 等. 第 7版 食管癌锁骨上淋巴结转移分期方式的探讨及152例病例分 析[J] 中国肿瘤临床, 2011, 38(23): 1458-63. ]
    [13]
    Liu W, Hao XS, Chen Y, et al. Lymph node metastases from carcinoma of the thoracic esophagus and cardia: a random sampling report of 1 526 cases[J]. Zhongguo Zhong Liu Lin Chuang, 2008, 35(11): 601-6. [刘巍, 郝希山, 陈勇, 等. 1 526例 胸段食管癌及贲门癌淋巴结转移状况分析(附1996～2004年河 北医科大学第四医院随机抽样报告)[J]. 中国肿瘤临床, 2008, 35 (11): 601-6.]
    [14]
    Zhen CJ, Zhou ZG, Song YZ, et al. Analysis of therapeutic effect and prognosis of radiotherapy for patients with esophageal carcinoma with supraclavicular lymph node metastasis[J]. Zhong Liu Fang Zhi Yan Jiu, 2013, 40(1): 90-4. [甄婵军, 周志国, 宋玉 芝, 等. 食管癌锁骨上淋巴结转移
    • Related Articles

  • Related Articles

    [1]ZHANG Wenlong, ZHANG Panpan, SI Jiahui, MA Yuanyuan, YANG Yue. HLA-G Expression in Lung Adenocarcinoma Tissues and Its Relationship with Prognosis[J]. Cancer Research on Prevention and Treatment, 2018, 45(8): 566-570. DOI: 10.3971/j.issn.1000-8578.2018.17.1594
    [2]ZHOU Yan, WU Zhencun, CHENG Jianjun, JIA Tianjun. Association of HLA-E Gene Polymorphisms with Genetic Susceptibility to Breast Carcinoma[J]. Cancer Research on Prevention and Treatment, 2015, 42(02): 190-193. DOI: 10.3971/j.issn.1000-8578.2015.02.020
    [3]Liu Yangzheng, Hu Jianming, Li Feng, Li Ling, Yan Xiaolong, Li Xin, Chen Wenjuan, Xiong Yangyang. Expression and Significance of HLA-G in Kazak Patients with Esophageal Squamous Cell Carcinoma[J]. Cancer Research on Prevention and Treatment, 2013, 40(02): 164-167. DOI: 10.3971/j.issn.1000-8578.2013.02.010
    [4]Nie Yanli, Ruan Zhiping, Nan Kejun. Expressions of DR5，caspase-8，caspase-9 and caspase-3 in HepG2 Cell Line Treated with Gemcitabine[J]. Cancer Research on Prevention and Treatment, 2013, 40(02): 134-137. DOI: 10.3971/j.issn.1000-8578.2013.02.003
    [6]QI Feng, GAO Yan-feng, SUN Zhan-qiang, HU Hong-min, CHEN Li-xiang, QI Yuan-ming. Identification and Optimization of HLA-A2 Restricted COX-2 Derived Antigen Peptides[J]. Cancer Research on Prevention and Treatment, 2008, 35(07): 460-463. DOI: 10.3971/j.issn.1000-8578.1481
    [7]ZHOU Jian, MEI Jia-zhuan, GUO Kun-yuan, NIU Xin-qing, WANG Yang, TU San-fang, ZHOU Xue-yun. Aberrant Expression of NKG2D Ligand and High Expression HLA-Ⅰ Molecules May Contribute to Immune Escape from Natural Killer Cell-mediated Immune Surveillance of Malignant Gliomas[J]. Cancer Research on Prevention and Treatment, 2008, 35(04): 247-250. DOI: 10.3971/j.issn.1000-8578.1529
    [8]SONG Shu-xia, LIU Gui-ran, ZHENG Long, WANG Jun-xia, LIU Fu-ying. Construction of MAGE-3 Tumor Vaccine and Its Effect on CTL Activity in HLA-A * 0201 Mice[J]. Cancer Research on Prevention and Treatment, 2007, 34(10): 739-742. DOI: 10.3971/j.issn.1000-8578.900
    [9]SUN Zhan-qiang, LI Yong-xin, LOU Hui-ping, LI Jing-jing, CHEN Li-xiang, QI Yuan-ming. Prediction of HLA-A2/3 Restricted Cytototxic T Lymphocyte Epitopes in Hyper-expressed Antigens in Esophageal Carcinoma[J]. Cancer Research on Prevention and Treatment, 2007, 34(06): 412-415. DOI: 10.3971/j.issn.1000-8578.3219
    [10]ZHANG Su-fang, SHI Cheng-zhang. Significance of Dendritic Cells Infiltration and HLA-DR Antigen Expressed in Gastric Cancer and Precancerous Lesions[J]. Cancer Research on Prevention and Treatment, 2004, 31(05): 261-263. DOI: 10.3971/j.issn.1000-8578.2010

Catalog

    Get Citation
    PDF
    XML
    Article views (2189) PDF downloads (789) Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Download Center

    Links

    Contact Us

    Address：116 Zhuodaoquan South Road,
    Hongshan District, Wuhan（430079）

    Tel：027－87670126

    Email：zlfzyjzz@vip.163.com

    This work is licensed under a Creative Commons Attribution 3.0 License.

    Email Alert RSS
    Total visits：12458615 Visits today：7482

    Copyright © Editorial Department of Cancer Prevention Research 鄂公网安备 42011102005013号 鄂ICP备2022015867号

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return